To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission
Study limitation reported by the research below: “International survey responses may reflect heterogeneous practice guidelines and healthcare systems, reducing generalizability to any single clinical setting.”